PD-L1 Knock Out Mice

The signal and all of the immunoglobulin (Ig)-V-like exon of the CD274 antigen (Cd274) gene were replaced with a neomycin resistance cassette, abolishing PD-L1 gene expression. PD-L1 is one of two ligands for PD-1 and is upregulated on antigen presenting cells (APCs), activated T cells, myeloid cells, dendritic cells (DCs). It is also expressed on hematopoietic and parenchymal cells. PD-1 is an inhibitory receptor expressed on activated lymphocytes, regulates tolerance and autoimmunity by negative regulation of T cell responses. These mice are more susceptible to T cell-mediated tissue damage from autoimmune diabetes. They get accelerated diabetes after 2 generations of NOD backcrossing. All mice display accelerated diabetes between 4-7 weeks of age. When treated with anti-CD3 these mice develop a wasting disease between 12 and 20 weeks of age characterized by sudden deterioration, weight loss, and inflammation in the heart and skeletal muscles. This wasting disease leads to death within 3-5 days of development of illness. As homozygotes develop diabetes early, this line should be maintained as heterozygotes, although they also develop diabetes. The Jackson Laboratory 2024, used with permission.

Jax Stock Number: 18307

Additional Information